Insider Trading activities of Medgenics, Inc. insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Medgenics, Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Medgenics, Inc. since year 2005. Table 2 shows the detailed insider transactions of Medgenics, Inc. since 2005. The reporting company's ticker symbol is GNMC. The reporting company's CIK number is 1138776.
The total value of stock buying since 2005 is $13,888,928.
The total value of stock sales since 2005 is $3,089,086.
The total value of stock option exercises since 2005 is $2,660,007.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Medgenics, Inc. (GNMC).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-09 83,775 $100,530 0 $0 0 $0
2017-08 30,831 $36,792 0 $0 0 $0
2017-04 200,000 $311,000 0 $0 0 $0
2017-03 1,058,531 $1,883,649 0 $0 0 $0
2016-12 3,000 $15,798 0 $0 0 $0
2015-10 223,074 $1,449,981 0 $0 0 $0
2015-09 0 $0 94,825 $944,457 0 $0
2015-03 50,000 $422,499 50,000 $422,499 0 $0
2015-02 150,000 $1,115,500 0 $0 0 $0
2014-12 545,122 $2,234,994 0 $0 0 $0
2014-06 28,000 $222,936 0 $0 0 $0
2014-05 60,000 $414,300 0 $0 0 $0
2014-02 0 $0 31,168 $260,512 31,168 $91,367
2014-01 0 $0 105,000 $715,869 105,000 $288,900
2013-12 44,500 $265,205 22,000 $138,905 0 $0
2013-11 25,000 $170,125 0 $0 0 $0
2013-09 40,000 $241,480 0 $0 0 $0
2013-06 1,000 $4,139 0 $0 0 $0
2013-03 0 $0 0 $0 3,500 $12,740
2012-09 0 $0 43,462 $461,036 110,558 $796,647
2012-08 0 $0 11,635 $145,808 164,182 $1,206,737
2012-06 0 $0 0 $0 4,286 $28,073
2011-09 0 $0 0 $0 45,701 $113,795
2011-05 0 $0 0 $0 48,895 $121,748
2011-04 1,000,000 $5,000,000 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Medgenics, Inc. insiders (GNMC)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-09-01 Harper Philip R (10% Owner) Buy 83,775 1.20 100,530
2017-08-23 Harper Philip R (10% Owner) Buy 5,700 1.20 6,840
2017-08-22 Harper Philip R (10% Owner) Buy 4,661 1.20 5,593
2017-08-10 Harper Philip R (10% Owner) Buy 20,470 1.19 24,359
2017-04-28 Barer Sol J (Director) Buy 100,000 1.57 156,700
2017-04-26 Barer Sol J (Director) Buy 100,000 1.54 154,300
2017-03-24 Harper Philip R (10% Owner) Buy 53,826 1.60 86,121
2017-03-23 Harper Philip R (10% Owner) Buy 4,705 1.60 7,528
2017-03-22 Harper Philip R (10% Owner) Buy 1,000,000 1.79 1,790,000
2016-12-08 Grano Joseph J Jr (Director) Buy 3,000 5.27 15,798
2015-10-06 Neil Garry Arthur (Chief Scientific Officer) Buy 15,384 6.50 99,996
2015-10-06 Grano Joseph J Jr Buy 15,384 6.50 99,996
2015-10-06 Barer Sol J Buy 153,846 6.50 999,999
2015-10-06 Cola Michael F (President and CEO) Buy 38,460 6.50 249,990
2015-09-21 Blech Isaac (Director) Sale 94,825 9.96 944,457
2015-03-20 Barer Sol J Buy 50,000 8.45 422,499
2015-03-20 Bauer Eugene A Sale 50,000 8.45 422,499
2015-02-20 Barer Sol J Buy 50,000 7.55 377,500
2015-02-19 Barer Sol J Buy 100,000 7.38 738,000
2014-12-01 Applebaum Scott (Chief Legal Officer) Buy 6,098 4.10 25,001
2014-12-01 Neil Garry Arthur (Global Head of R&D) Buy 24,390 4.10 99,998
2014-12-01 Grano Joseph J Jr Buy 48,780 4.10 199,997
2014-12-01 Mcmurray Stephen D Buy 2,439 4.10 9,999
2014-12-01 Clemow Alastair J T Buy 12,195 4.10 49,999
2014-12-01 Barer Sol J Buy 365,854 4.10 1,500,001
2014-12-01 Gantz Wilbur H Buy 24,390 4.10 99,998
2014-12-01 Cola Michael F (President and CEO) Buy 60,976 4.10 250,001
2014-06-13 Barer Sol J Buy 28,000 7.96 222,936
2014-05-12 Barer Sol J Buy 60,000 6.91 414,300
2014-02-12 Pearlman Andrew Sale 11,168 9.00 100,512
2014-02-12 Pearlman Andrew Option Ex 11,168 3.14 35,067
2014-02-04 Pearlman Andrew Sale 20,000 8.00 160,000
2014-02-04 Pearlman Andrew Option Ex 20,000 2.81 56,300
2014-01-30 Pearlman Andrew Sale 24,500 7.50 183,750
2014-01-30 Pearlman Andrew Option Ex 24,500 3.14 76,930
2014-01-29 Pearlman Andrew Sale 500 7.50 3,750
2014-01-29 Pearlman Andrew Option Ex 500 3.14 1,570
2014-01-09 Pearlman Andrew Sale 34,466 6.69 230,577
2014-01-09 Pearlman Andrew Option Ex 34,466 2.81 97,021
2014-01-08 Pearlman Andrew Sale 45,534 6.54 297,792
2014-01-08 Pearlman Andrew Option Ex 45,534 2.49 113,379
2013-12-16 Clemow Alastair J T Buy 4,500 5.78 26,005
2013-12-13 Barer Sol J Buy 20,000 5.37 107,420
2013-12-06 Dellio Clarence L (Chief Operating Officer) Sale 2,000 6.50 13,000
2013-12-03 Bauer Eugene A Sale 5,000 6.35 31,750
2013-12-02 Barer Sol J Buy 20,000 6.59 131,780
2013-12-02 Bauer Eugene A Sale 15,000 6.28 94,155
2013-11-11 Barer Sol J Buy 25,000 6.80 170,125
2013-09-20 Barer Sol J Buy 20,000 6.50 130,000
2013-09-19 Barer Sol J Buy 20,000 5.57 111,480
2013-06-04 Dellio Clarence L (Chief Operating Officer) Buy 712 4.14 2,947
2013-06-03 Dellio Clarence L (Chief Operating Officer) Buy 288 4.14 1,192
2013-03-20 Dellio Clarence L (Chief Operating Officer) Option Ex 3,500 3.64 12,740
2012-09-21 Bellin Phyllis K. (See Remarks) Sale 400 10.90 4,360
2012-09-20 Bellin Phyllis K. (See Remarks) Sale 5,082 10.92 55,495
2012-09-20 Bellomo Stephen (See Remarks) Sale 350 10.99 3,846
2012-09-18 Pearlman Andrew (President and CEO) Sale 5,000 10.24 51,200
2012-09-17 Pearlman Andrew (President and CEO) Sale 6,000 10.29 61,739
2012-09-14 Pearlman Andrew (President and CEO) Sale 4,000 10.73 42,920
2012-09-14 Dellio Clarence L (Chief Operating Officer) Sale 3,007 10.74 32,295
2012-09-13 Pearlman Andrew (President and CEO) Sale 19,623 10.66 209,181
2012-09-11 Bellin Phyllis K. (See Remarks) Option Ex 13,964 7.35 102,635
2012-09-11 Pearlman Andrew (President and CEO) Option Ex 91,403 7.35 671,812
2012-09-11 Dellio Clarence L (Chief Operating Officer) Option Ex 4,300 3.64 15,652
2012-09-10 Bellomo Stephen (See Remarks) Option Ex 891 7.35 6,548
2012-08-30 Kanter Joel S Sale 700 13.03 9,121
2012-08-24 Mcmurray Stephen D Sale 10,935 12.50 136,687
2012-08-22 Bauer Eugene A Option Ex 82,327 7.35 605,103
2012-08-17 Mcmurray Stephen D Option Ex 33,052 7.35 242,932
2012-08-17 Kanter Joel S Option Ex 38,803 7.35 285,202
2012-08-16 Kanter Joel S Option Ex 10,000 7.35 73,500
2012-06-21 Kanter Joel S Option Ex 4,286 6.55 28,073
2011-09-07 Brukardt Gary A Option Ex 45,701 2.49 113,795
2011-05-11 Stern Baruch (Chief Scientific Officer) Option Ex 48,895 2.49 121,748
2011-04-13 West Charitable Remainder Unitrust (Other) Buy 1,000,000 5.00 5,000,000

Insider trading activities including stock purchases, stock sales, and option exercises of GNMC listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Medgenics, Inc. (symbol GNMC, CIK number 1138776) see the Securities and Exchange Commission (SEC) website.